Brachytherapy Combined With or Without Hormone Therapy for Localized Prostate Cancer: A Meta-Analysis and Systematic Review

Frontiers in Oncology
Xueliang ZhouXinwei Han

Abstract

Purpose: The purpose of this study was to evaluate the efficacy of brachytherapy combined with or without hormone therapy in patients with localized prostate cancer. Methods and Materials: We systemically searched the Medline, Web of Science, Cochrane Library and Embase databases for studies published between the databases' dates of inception and February 2019. The primary endpoints were the 5-year overall survival (OS) rates, 5-year biochemical progression-free survival (bPFS) rates and 10-year bPFS rates. The results were expressed as the relative risk (RR) and 95% confidence interval (CI). Based on the heterogeneity evaluated with the I2 statistic, a meta-analysis was performed using either a random- or fixed-effects model. Results: A total of 16 cohort studies including 9,359 patients met all the criteria for inclusion in the analysis. Our data showed that brachytherapy (BT) combined with hormone therapy (HT) increased the patients' 5-year bPFS rates (RR = 1.04, 95% CI: 1.01-1.08, P = 0.005) and 10-year bPFS rates (RR = 1.12, 95% CI: 1.02-1.23, P = 0.001) compared with BT monotherapy. However, BT combined with HT did not increase the patients' 5-year OS rates (RR = 1.02, 95% CI: 0.99-1.095, P = 0.1) compared with BT monothe...Continue Reading

References

Dec 1, 1972·The Journal of Urology·W F WhitmoreH Grabstald
Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W PistersM F Brennan
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L PottersS Leibel
Jun 6, 2000·International Journal of Radiation Oncology, Biology, Physics·H MarsigliaA Gerbaulet
Aug 23, 2001·International Journal of Radiation Oncology, Biology, Physics·G S MerrickJ H Lief
Mar 2, 2002·International Journal of Radiation Oncology, Biology, Physics·Lucille N LeeNelson N Stone
Oct 16, 2002·International Journal of Radiation Oncology, Biology, Physics·Jesse N Aronowitz
Apr 12, 2003·The Lancet Oncology·Richard E Peschel, John W Colberg
Jan 14, 2005·The New England Journal of Medicine·Vahakn B ShahinianJames S Goodwin
May 14, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Dan AshJoji Joseph
Sep 16, 2006·BMJ : British Medical Journal·Joseph LauIngram Olkin
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy L KeatingMatthew R Smith
Dec 1, 1924·Annals of Surgery·B S Barringer
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity·Matthew R Smith
Jan 24, 2008·JAMA : the Journal of the American Medical Association·Anthony V D'AmicoPhilip W Kantoff
May 23, 2008·International Journal of Radiation Oncology, Biology, Physics·Dietmar GeorgRichard Pötter
Aug 12, 2008·International Journal of Radiation Oncology, Biology, Physics·Christopher A PetersNelson N Stone
Jul 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony V D'AmicoMing-Hui Chen
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Mar 9, 2010·International Journal of Radiation Oncology, Biology, Physics·Eric T ShinoharaJames M Metz
Jul 15, 2011·The New England Journal of Medicine·Christopher U JonesWilliam U Shipley
Feb 22, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Peter J HoskinLinda Bryant
Mar 30, 2013·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·M DelannesI David
Oct 31, 2013·International Journal of Clinical Oncology·Shuichi NishimuraNaoyuki Shigematsu
Sep 25, 2014·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Tobin J StromRichard B Wilder
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Feb 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm D MasonPadraig Warde
May 13, 2015·International Journal of Radiation Oncology, Biology, Physics·Jeffrey A KittelJay P Ciezki
Aug 10, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Robert F WolffJos Kleijnen
Jan 28, 2016·Journal of Contemporary Brachytherapy·Sarbani Ghosh LaskarPrachi Patil
Nov 28, 2016·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·György KovácsUNKNOWN GEC-ESTRO Head & Neck Working Group

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.